跳至主要内容
临床试验/NL-OMON30421
NL-OMON30421尚未招募4 期

The METEX Study: methotrexate versus expectant management in women with ectopic pregnancy - METEX Study

Academisch Medisch Centrum0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All hemodynamically stable patients >= 18 years with either an ectopic pregnancy (a visible ectopic pregnancy or an ectopic mass on transvaginal sonography) and a plateauing serum hCG concentration < 1,500 IU/L or with a Pregnancy of Unknown Location (PUL) and a plateauing serum hCG concentration < 2,000 IU/L (persisting PUL).

排除标准

  • Patients with a viable ectopic pregnancy, signs of tubal rupture and/or active intra abdominal bleeding or abnormalities in liver or renal function or in full blood count.

研究者

相似试验

The METEX Study: methotrexate versus expectant... | 临床试验